1. Home
  2. NVCR vs VTLE Comparison

NVCR vs VTLE Comparison

Compare NVCR & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VTLE
  • Stock Information
  • Founded
  • NVCR 2000
  • VTLE 2006
  • Country
  • NVCR Jersey
  • VTLE United States
  • Employees
  • NVCR N/A
  • VTLE N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VTLE
  • Sector
  • NVCR Health Care
  • VTLE
  • Exchange
  • NVCR Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • NVCR 1.8B
  • VTLE 1.1B
  • IPO Year
  • NVCR 2015
  • VTLE 2011
  • Fundamental
  • Price
  • NVCR $17.49
  • VTLE $27.25
  • Analyst Decision
  • NVCR Buy
  • VTLE Hold
  • Analyst Count
  • NVCR 5
  • VTLE 13
  • Target Price
  • NVCR $26.60
  • VTLE $47.91
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • VTLE 1.0M
  • Earning Date
  • NVCR 10-30-2024
  • VTLE 11-06-2024
  • Dividend Yield
  • NVCR N/A
  • VTLE N/A
  • EPS Growth
  • NVCR N/A
  • VTLE N/A
  • EPS
  • NVCR N/A
  • VTLE 8.51
  • Revenue
  • NVCR $549,964,000.00
  • VTLE $1,838,745,000.00
  • Revenue This Year
  • NVCR $16.23
  • VTLE $28.00
  • Revenue Next Year
  • NVCR $6.09
  • VTLE $9.74
  • P/E Ratio
  • NVCR N/A
  • VTLE $3.10
  • Revenue Growth
  • NVCR 8.33
  • VTLE 22.93
  • 52 Week Low
  • NVCR $10.87
  • VTLE $25.85
  • 52 Week High
  • NVCR $24.74
  • VTLE $58.30
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • VTLE 42.98
  • Support Level
  • NVCR $15.61
  • VTLE $25.85
  • Resistance Level
  • NVCR $17.31
  • VTLE $28.36
  • Average True Range (ATR)
  • NVCR 1.29
  • VTLE 1.03
  • MACD
  • NVCR 0.05
  • VTLE 0.03
  • Stochastic Oscillator
  • NVCR 11.59
  • VTLE 28.87

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: